ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1164508
BOSTON, MA
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$285,316,733
+$16,044,922 QoQ
Shares Held
638,950
+7.6% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 93.07551451600283.ToString("F0")%
Shared 0.ToString("F0")%
None 6.9244854839971826.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $1,776,833,332 across 48 Biotechnology names. VRTX ranks #1 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
638,950 | $285,316,733 | |
| 2 | INCY |
Incyte Corp
|
2,830,799 | $266,434,801 | |
| 3 | EXEL |
Exelixis, Inc.
|
4,834,625 | $207,357,066 | |
| 4 | GMAB |
Genmab A/S
|
4,975,324 | $133,487,942 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
171,571 | $132,562,617 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,918,149 | $123,969,969 | |
| 7 | RPRX |
Royalty Pharma plc
|
2,010,398 | $96,438,792 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
737,859 | $55,405,832 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $285,316,733 | 638,950 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $269,271,811 | 593,947 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $149,291,209 | 381,195 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $27,366,444 | 61,470 | Shares | Defined | 2025-08-13 | |
| 2024-12-31 | $3,731,015 | 9,265 | Shares | Defined | 2025-02-12 | |
| 2022-12-31 | $1,511,185 | 5,233 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,474,337 | 5,092 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,758,724 | 9,790 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $5,325,080 | 24,249 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $65,349,291 | 324,105 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $46,751,683 | 217,561 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $92,361,435 | 390,799 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $26,127,057 | 96,013 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $23,974,380 | 82,582 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $16,698,379 | 70,176 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||